Dr. Davey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Crc 4 1479 Bldg 10
10 Center Drive Msc 1460
Bethesda, MD 20892Phone+1 301-496-8029Fax+1 301-480-5560- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1984 - 1987
- Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
Certifications & Licensure
- MD State Medical License 1984 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies Start of enrollment: 1984 Jan 09
- Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies Start of enrollment: 2003 Dec 01
- Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study Start of enrollment: 2008 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- 903 citationsA Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.Sabue Mulangu, Lori E. Dodd, Richard T. Davey, Tshiani Mbaya O, Proschan M
The New England Journal of Medicine. 2019-12-12 - 34 citationsGenetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral TherapyMark Dybul, Marybeth Daucher, Mark A. Jensen, Claire W. Hallahan, Tae Wook Chun
Journal of Virology. 2003-03-01 - 34 citationsRapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.J. M. Orenstein, Niranjan Bhat, Christian Yoder, Cecil H. Fox, Michael A. Polis
AIDS. 2000-08-18
Journal Articles
- Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 TranslationRichard T Davey, John H Beigel, British Journal of Clinical Pharmacology
Grant Support
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2009–2011
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2009–2011
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeutiNational Institute Of Allergy And Infectious Diseases2002–2006
- Immunologic/Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2005
- Immunologic &Virologic Approaches To HIV 1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2001
- Immunologic And Virologic Approaches To HIV1 TherapeuticNational Institute Of Allergy And Infectious Diseases2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: